Collaborative Drug Discovery (United States)

Collaborative Drug Discovery (United States)

Collaborative Drug Discovery is a software company founded in 2004 as a spin-out of Eli Lilly by Barry Bunin, PhD. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Collaborative Drug Discovery (United States), United States, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

59%


Total
Publications

122


Total Open
Publications

72


Total
Citations

3.2K


Open Access
Percentage

59%


Total
Publications

122


Total Open
Publications

72


Total
Citations

3.2K

Wikipedia

Website

download

Breakdown

13% 31% 15% 41%

Publisher Open

13%

Both

31%

Other Platform Open

15%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

25

Hybrid 39%

21

No Guarantees 15%

8

Other Platform Open

Domain 82%

46

Public 20%

11

Institution 14%

8

Other Internet 7%

4

Preprint 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
45
Europe PMC
Domain
34
Semantic Scholar
Public
8
University of Edinburgh - Edinburgh Research Explorer
Institution
5
University of California - eScholarship University of California
Institution
2
Figshare
Public
2
DOI
Other Internet
2
Zenodo
Public
1
University of Luxembourg - ORBilu: Open Repository and Bibliography
Institution
1
Swiss Federal Laboratories for Materials Science and Technology (Empa) - DORA Empa
Other Internet
1
1 / 2

Data updated 7 October 2024

Share

Share

Share